TREVQ yields 2000000.00% · PFE yields 6.13%● Live data
📍 TREVQ pulled ahead of the other in Year 1
Combined, TREVQ + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TREVQ + PFE for your $10,000?
Trevali Mining Corporation, a base-metals mining company, engages in the acquisition, exploration, development of, and production from mineral properties. It primarily explores for zinc, lead, silver, copper, and gold deposits. The company's operational assets include the 90%-owned Perkoa Mine in Burkina Faso; 90%-owned Rosh Pinah Mine in Namibia; and Caribou Mine in northern New Brunswick, Canada. It also holds interests in the Halfmile, Stratmat, and Restigouche properties situated in New Brunswick, Canada; Gergarub project in Namibia; and Ruttan Mine located in northern Manitoba, Canada. In addition, the company has an option to acquire a 100% interest in the Heath Steele deposit located in New Brunswick, Canada. Trevali Mining Corporation was formerly known as Trevali Resources Corp. and changed its name to Trevali Mining Corporation in April 2011. The company was incorporated in 1964 and is headquartered in Vancouver, Canada.
Full TREVQ Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.